Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Accumulated Expenses (2021 - 2022)

Trulieve Cannabis has reported Accumulated Expenses over the past 2 years, most recently at $19.5 million for Q4 2022.

  • Quarterly results put Accumulated Expenses at $19.5 million for Q4 2022, down 20.95% from a year ago — trailing twelve months through Dec 2022 was $19.5 million (down 20.95% YoY), and the annual figure for FY2022 was $19.5 million, down 20.95%.
  • Accumulated Expenses for Q4 2022 was $19.5 million at Trulieve Cannabis, down from $27.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for TCNNF hit a ceiling of $27.2 million in Q1 2022 and a floor of $19.5 million in Q4 2022.